Sex-specific survival in advanced metastatic melanoma – a DeCOG study on 2032 patients of the multicenter prospective skin cancer registry ADOREG
Anna‐Sophia Leven(Essen University Hospital), Selma Ugurel(Klinikum Bielefeld), Patrick Terheyden(University Hospital Schleswig-Holstein), Carola Berking(Friedrich-Alexander-Universität Erlangen-Nürnberg), Dirk Debus(Nuremberg Hospital), Rudolf Herbst(Helios Klinikum Erfurt), Ralf Gutzmer(University Hospitals of the Ruhr-University of Bochum), Christoffer Gebhardt(Universität Hamburg), Michael Weichenthal(Christian-Albrechts-Universität zu Kiel), Claudia Pföhler(Saarland University), Alexander Roesch(Essen University Hospital), Triinu Peters(Essen University Hospital), Andrea Forschner(University of Tübingen), Luisa Sophie Rajcsanyi(University of Duisburg-Essen), Dirk Schadendorf(National Center for Tumor Diseases), Friedegund Meier(National Center for Tumor Diseases), Jochen Utikal(Heidelberg University), Stephan Grabbe(Goethe University Frankfurt), Julia Welzel(University Hospital Augsburg), Alpaslan Tasdogan(Düsseldorf University Hospital), Elisabeth Livingstone(German Cancer Research Center), Peter J. Mohr(Roche (Switzerland)), Thilo Gambichler(Witten/Herdecke University), Lisa Zimmer(The University of Sydney), Jürgen C. Becker(Düsseldorf University Hospital), Jessica C. Hassel(German Cancer Research Center), Carmen Loquai(Johannes Gutenberg University Mainz), Mirjana Ziemer(University Medical Center), Alexander Kreuter(HELIOS St. Elisabeth Klinik Oberhausen), Ulrike Leiter(University of Tübingen), Sebastian Haferkamp(University Hospital Regensburg), Stine Lutze(Universitätsmedizin Greifswald), Carsten Weishaupt(University Hospital Münster), Imke von Wasielewski(Medizinische Hochschule Hannover), Anke Hinney(Philipps University of Marburg)
Cited by 4
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Nivolumab in Previously Untreated Melanoma without <i>BRAF</i> Mutation
|New England Journal of Medicine|2014|5.3k